ARROWHEAD PHARMACEUTICALS, INC. short interest in 2020
In 2020, ARROWHEAD PHARMACEUTICALS, INC.'s disclosed short interest ran from 11.51% of shares outstanding on 15 Jan 2020 to 5.76% on 31 Dec 2020, a change of -5.75 percentage points. The year's high was 11.51% on 15 Jan 2020 and its low 5.76% on 31 Dec 2020, averaging 8.62% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 13.02 days on 31 Aug 2020. Full history: ARROWHEAD PHARMACEUTICALS, INC..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2020 in figures
- Start of year
- 11.51% (15 Jan 2020)
- End of year
- 5.76% (31 Dec 2020)
- Change
- -5.75 pp
- High
- 11.51% (15 Jan 2020)
- Low
- 5.76% (31 Dec 2020)
- Average
- 8.62%
- Highest days to cover
- 13.02 (31 Aug 2020)
- SEC filings marked
- 8
Every report in 2020
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2020 | 11.51% | 7.78 | |
| 31 Jan 2020 | 10.47% | 5.17 | |
| 14 Feb 2020 | 9.37% | 6.55 | 10-Q filed, results (8-K) |
| 28 Feb 2020 | 8.58% | 5.33 | |
| 13 Mar 2020 | 8.14% | 5.21 | |
| 31 Mar 2020 | 7.54% | 3.84 | |
| 15 Apr 2020 | 7.51% | 7.13 | |
| 30 Apr 2020 | 7.84% | 7.49 | |
| 15 May 2020 | 7.90% | 6.80 | 10-Q filed, results (8-K) |
| 29 May 2020 | 8.18% | 8.09 | |
| 15 Jun 2020 | 8.25% | 9.18 | |
| 30 Jun 2020 | 9.82% | 7.26 | |
| 15 Jul 2020 | 10.12% | 10.60 | |
| 31 Jul 2020 | 9.61% | 12.75 | |
| 14 Aug 2020 | 9.30% | 11.89 | 10-Q filed, results (8-K) |
| 31 Aug 2020 | 9.21% | 13.02 | |
| 15 Sep 2020 | 8.86% | 8.13 | |
| 30 Sep 2020 | 8.81% | 2.56 | |
| 15 Oct 2020 | 9.12% | 10.76 | |
| 30 Oct 2020 | 8.12% | 6.14 | |
| 13 Nov 2020 | 8.02% | 9.50 | |
| 30 Nov 2020 | 7.65% | 6.33 | 10-K filed, results (8-K) |
| 15 Dec 2020 | 7.23% | 8.67 | |
| 31 Dec 2020 | 5.76% | 6.12 |
See also: ARROWHEAD PHARMACEUTICALS, INC.'s full history · most shorted US stocks of 2020 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.